These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26916216)

  • 1. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
    Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
    Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C
    Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer.
    Du M; Shi D; Yuan L; Li P; Chu H; Qin C; Yin C; Zhang Z; Wang M
    Sci Rep; 2015 May; 5():10437. PubMed ID: 26014226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia.
    Elhamamsy AR; El Sharkawy MS; Zanaty AF; Mahrous MA; Mohamed AE; Abushaaban EA
    Int J Mol Cell Med; 2017; 6(2):77-86. PubMed ID: 28890884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
    Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X
    Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.
    Lu C; Lin S; Wen Z; Sun C; Ge Z; Chen W; Li Y; Zhang P; Wu Y; Wang W; Chen S; Zhou H; Li X; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Wu X; Lai Y
    Biomarkers; 2024 Jul; 29(5):276-284. PubMed ID: 38767408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma microRNA profiles for bladder cancer detection.
    Adam L; Wszolek MF; Liu CG; Jing W; Diao L; Zien A; Zhang JD; Jackson D; Dinney CP
    Urol Oncol; 2013 Nov; 31(8):1701-8. PubMed ID: 22863868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer.
    Si H; Sun X; Chen Y; Cao Y; Chen S; Wang H; Hu C
    J Cancer Res Clin Oncol; 2013 Feb; 139(2):223-9. PubMed ID: 23052693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: An Egyptian study.
    Elshafei A; Shaker O; Abd El-Motaal O; Salman T
    Tumour Biol; 2017 Jun; 39(6):1010428317705765. PubMed ID: 28618945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
    Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased serum miR-181a is a potential new tool for breast cancer screening.
    Guo LJ; Zhang QY
    Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
    Scheffer AR; Holdenrieder S; Kristiansen G; von Ruecker A; Müller SC; Ellinger J
    World J Urol; 2014 Apr; 32(2):353-8. PubMed ID: 23266581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
    Shi Y; Liu Z
    J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
    Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma miR-92a-2 as a biomarker for small cell lung cancer.
    Yu Y; Zuo J; Tan Q; Zar Thin K; Li P; Zhu M; Yu M; Fu Z; Liang C; Tu J
    Cancer Biomark; 2017; 18(3):319-327. PubMed ID: 28106539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
    Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
    Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma.
    Kirschner MB; Cheng YY; Badrian B; Kao SC; Creaney J; Edelman JJ; Armstrong NJ; Vallely MP; Musk AW; Robinson BW; McCaughan BC; Klebe S; Mutsaers SE; van Zandwijk N; Reid G
    J Thorac Oncol; 2012 Jul; 7(7):1184-91. PubMed ID: 22617246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.